Antithrombin III Doses Rounded to Available Vial Sizes in Critically Ill Pediatric Patients.

about

Antithrombin III Doses Rounded to Available Vial Sizes in Critically Ill Pediatric Patients.

Item

http://www.wikidata.org/entity/Q39197597

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Antithrombin III Doses Rounded ...... ically Ill Pediatric Patients.

@en

Antithrombin III Doses Rounded ...... ically Ill Pediatric Patients.

@nl

type

Item

label

Antithrombin III Doses Rounded ...... ically Ill Pediatric Patients.

@en

Antithrombin III Doses Rounded ...... ically Ill Pediatric Patients.

@nl

prefLabel

Antithrombin III Doses Rounded ...... ically Ill Pediatric Patients.

@en

Antithrombin III Doses Rounded ...... ically Ill Pediatric Patients.

@nl

P1476

Antithrombin III Doses Rounded ...... ically Ill Pediatric Patients.

@en

P2093

Carolyn E Ragsdale

http://www.w3.org/2001/XMLSchema#string

Eimeira Padilla-Tolentino

http://www.w3.org/2001/XMLSchema#string

Winifred M Stockton

http://www.w3.org/2001/XMLSchema#string

P2860

Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology

Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.

Initial experience with recombinant antithrombin to treat antithrombin deficiency in patients on extracorporeal membrane oxygenation

Antithrombin concentrate use in children: a multicenter cohort study.

Antithrombin replacement during extracorporeal membrane oxygenation.

Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation.

Antithrombin concentrate in pediatric patients requiring unfractionated heparin anticoagulation: a retrospective cohort study.

The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.

Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.

Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life.

P304

15-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5863/1551-6776-22.1.15

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28337077

http://www.w3.org/2001/XMLSchema#string

P932

5341527

http://www.w3.org/2001/XMLSchema#string